Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026)
Senseonics Holdings (SENS) posted quarterly Net Income towards Common Stockholders of -$41.0 million for Q1 2026, down 91.26% year-over-year from -$468.7 million in Q1 2025, and down 105.69% quarter-over-quarter from -$19.9 million in Q4 2025.
Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Net Income towards Common Stockholders for 12 consecutive years, with -$41.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 91.26% year-over-year to -$41.0 million; the TTM figure through Mar 2026 stood at -$109.1 million (down 24.22% YoY), while the FY2025 annual figure was -$72.0 million, up 8.56% from the prior year.
- Net Income towards Common Stockholders retreated to -$41.0 million in Q1 2026 per SENS's latest filing, from -$19.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$14.3 million in Q4 2024 and bottomed at -$41.0 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$23.2 million across 5 years, with a median of -$21.7 million in 2025.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 230.98% — and 2024, when it surged 39.92%.
- Senseonics Holdings' Net Income towards Common Stockholders stood at -$19.3 million in 2022, then retreated by 23.14% to -$23.8 million in 2023, then soared by 39.92% to -$14.3 million in 2024, then sank by 39.13% to -$19.9 million in 2025, then slumped by 105.69% to -$41.0 million in 2026.
- Business Quant data shows SENS's Net Income towards Common Stockholders at -$41.0 million in Q1 2026, -$19.9 million in Q4 2025, and -$26.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Senseonics Holdings | 509.02 Mn | 268.41 Mn | 8.56 Mn | -36.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.71 Mn |
| Mar 31, 2026 | -40.96 Mn |
| Dec 31, 2025 | -19.92 Mn |
| Sep 30, 2025 | -26.50 Mn |
| Jun 30, 2025 | -21.72 Mn |
| Mar 31, 2025 | -21.42 Mn |
| Dec 31, 2024 | -14.31 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Jun 30, 2024 | -21.19 Mn |
| Mar 31, 2024 | -18.90 Mn |
| Dec 31, 2023 | -23.82 Mn |
| Sep 30, 2023 | -27.59 Mn |
| Jun 30, 2023 | -22.01 Mn |
| Mar 31, 2023 | -23.25 Mn |
| Dec 31, 2022 | -19.35 Mn |
| Sep 30, 2022 | -21.83 Mn |
| Jun 30, 2022 | -21.31 Mn |
| Mar 31, 2022 | -19.56 Mn |
| Dec 31, 2021 | -5.85 Mn |
| Sep 30, 2021 | -19.79 Mn |